The aims of this paper are to study the e¤ects of mergers on the R&D activity of consolidated
rms and to explore the relationship between ex-ante relatedness of merging parties and their ex-post performances. The analysis is conducted using data of the pharmaceutical industry for the period 1988-2004. The empirical results suggest that merged companies have on average, worst performances than ...